Low-dose oral contraceptives and bone mineral density: An evidence-based analysis

Contraception

Volumn 61, Issue 2, 2000, Pages 77-82

  Kuohung, Wendy ^a   Borgatta, Lynn ^a   Stubblefield, Phillip ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Bone mineral density; Oral contraceptives

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

BONE DENSITY; CONTRACEPTION; DENSITOMETRY; DRUG EFFECT; ESTROGEN DEFICIENCY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; OSTEOPOROSIS; REVIEW;

AMERICAS; BIOLOGY; CONTRACEPTION; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; FAMILY PLANNING; LITERATURE REVIEW; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, LOW-DOSE; PHYSIOLOGY; SKELETAL EFFECTS--WOMEN; UNITED STATES; WOMEN;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; CONTRACEPTIVES, ORAL, HORMONAL; ETHINYL ESTRADIOL; FEMALE; HUMANS; MEDLINE; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES;

EID: 0034053942     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(00)00086-X     Document Type: Review

References (39)

1. Reproductive health in the perimenopause. Contracept Rep. 4:1993;1-10.
2. Christiansen C., Lindsay R. Estrogens, bone loss, and preservation. Osteoporosis Int. 1:1990;7-13.
3. Cohn S.H., Vaswani A., Zanzi I., et al. Effect of aging on bone mass in adult women. Am J Physiol. 230:1976;143.
4. Goldsmith N.F., Johnston J.O. Bone mineral effects of oral contraceptives, pregnancy, and lactation . J Bone Joint Surg. 57A:1975;657-668.
5. Kleerekoper M., Brienza R.S., Schultz L.R., Johnson C.C. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med. 151:1991;1971-1976.
6. Enzelsberger H., Metka M., Heytmanek G., Schurz B., Kurz C., Kusztrich M. Influence of oral contraceptive use on bone density in climacteric women. Maturitas. 9:1988;375-378.
7. Stevenson J.C., Lees B., Davenport M., Cust M.P., Ganger K.F. Determinants of bone density in normal women risk factors for future osteoporosis? Br Med J. 298:1989;924-928.
8. Kritz-Silverstein D., Barrett-Connor E. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health. 83:1993;100-102.
9. Fortney J.A., Feldblum P.J., Talmage R.V., Zhang J., Godwin S.E. Bone mineral density and history of oral contraceptive use. J Reprod Med. 39:1994;105-109.
10. Mallmin H., Ljunghall S., Persson I., Bergström R. Risk factors for fractures of the distal forearm a population-based case-control study . Osteoporosis Int. 4:1994;298-304.
11. Hansen M.A., Overgaard K., Riis B.J., Christiansen. Potential risk factors for development of postmenopausal osteoporosis - examined over a 12-year period. Osteoporosis Int. 1:1991;95-102.
12. Cooper C., Hannaford P., Croft P., Kay C.R. Oral contraceptive pill use and fractures in women a prospective study . Bone. 14:1993;41-45.
13. Vessey M., Mant J., Painter R. Oral contraception and other factors in relation to hospital referral for fracture. Contraception. 57:1998;231-235.
14. Johnell O., Nilsson B.E. Life-style and bone mineral mass in perimenopausal women. Calcif Tissue Int. 36:1984;354-356.
15. Collins C.L., Thomas K.A., Harding A.F., Cook S.D., Turner J.L., Collins J.H. The effect of oral contraceptives on lumbar bone density in premenopausal women. J Louisiana St Med Soc. 140:1988;35-39.
16. Hreshchyshyn M.M., Hopkins A., Zylstra S., Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol. 159:1988;318-322.
17. Lloyd T., Buchanan J.R., Ursino G.R., Myers C., Woodward G., Halbert D.R. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol. 160:1989;402-404.
18. Guide to clinical preventive services, 2nd ed. 1996;Williams and Wilkins, Baltimore, Maryland.
19. Kanders B, Lindsay R, Dempster D et al. Determinants of bone mass in healthy young women. Proceedings of the Copenhagen International Symposium of Osteoporosis. Copenhagen, 1984:337-339.
20. Shargil A.A. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound a three-year prospective study . Int J Fertil. 30:1985;15-28.
21. Recker R.R., Davies Hinders S.M., Heaney R.P., Stegman M.R., Kimmel D.B. Bone gain in young adult women. JAMA. 268:1992;2403-2408.
22. Mais V., Fruzzetti F., Ajosssa S., Paoletti A.M., Guerriero S., Melis G.B. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol a prospective study . Contraception. 48:1993;445-452.
23. Volpe A., Silferi M., Genazzani A.D., Genazzani A.R. Contraception in older woman. Contraception. 47:1993;229-239.
24. Gambacciani M., Spinetti A., Taponeco F., Cappagli B., Piaggesi L., Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism . Obstet Gynecol. 83:1994;392-395.
25. Gambacciani M., Spinetti A., Cappagli B., et al. Hormone replacement therapy in perimenopausal women with a low-dose oral contraceptive preparation effects on bone mineral density and metabolism . Maturitas. 19:1994;125-131.
26. Volpe A., Amram A., Cagnacci A., Battaglia A. Biochemical aspects of hormonal contraception effects on bone metabolism . Eur J Contraception Repro Health Care. 2:1997;123-126.
27. Masaryk P., Lunt M., Benevolenskaya L., et al. Effects of menstrual history and use of medications on bone mineral density the EVOS Study . Calcif Tissue Int. 63:1998;271-276.
28. Sowers M., Wallace R.B., Lenke J.H. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med. 14:1985;585-596.
29. Mazess R.B., Barden H.S. Bone density in premenopausal women effects of age, dietary intake, physical activity, smoking, and birth-control pills . Am J Clin Nutr. 53:1991;132-142.
30. Rodin A., Chapman M., Fogelman I. Bone density in users of combined oral contraception. Br J Family Plann. 16:1991;125.
31. Murphy S., Khaw K.T., Compston J.E. Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest. 23:1993;108-111.
32. Mishell D.R. Contraception. N Engl J Med. 320:1989;777-787.
33. Mishell D.R., Darney P.D., Burkman R.T., Sulak P.J. Practice guidelines for OC selection Update . Dialogu Contracept. 5:1997;7-19.
34. Aitken J.M., Hart D.M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 3:1973;515-518.
35. Simpson G.R., Dale E. Serum levels of phosphorus, magnesium and calcium in women utilizing combination oral or long-acting injectable progestational contraceptives. Fertil Steril. 23:1972;326-330.
36. Horsman A., Jones M., Francis R., Nordin C. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med. 309:1983;1405-1407.
37. Lindsay R., Tohme J., Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception. 34:1986;333-340.
38. Michaelsson K., Baron J.A., Farahmand B.Y., et al. Oral contraceptive use and risk of hip fracture A case-control study . Lancet. 353:1999;1481-1484.
39. Hall M.L., Heavens J., Cullum I.D., Ell P.J. The range of bone density in normal British women. Br J Radiol. 63:1990;266-269.